In this video, Michael J. Bloch, MD, reviews and discusses a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including how the results...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this video, Michael J. Bloch, MD, discusses cardiovascular disease in women, including a woman's premenopausal life and its impact on cardiovascular disease risk post-menopausally and the management of...
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
In this interview, Jacob C. Jentzer, MD, Assistant Professor of Medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
In this video, Michael J. Bloch, MD, discusses the implications of a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including gaps in the...
In this episode, Seth Martin, MD, speaks with Francoise Marvel, MD, about innovative approaches to implementing prevention guidelines, including the future of digital health and cardiovascular care.
In this podcast, Robert P. Guigliano, MD, SM, discusses the findings from a secondary analysis from the IMPROVE-IT study on the association of serial high-sensitivity cardiac troponin T with subsequent...
